CUVL — Clinuvel Pharmaceuticals Ltd

Nasdaq · Unknown · Unknown · CIK 1290877 · Australia
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2025 271,750,012 224,105,942 30,941,386

Balance + Analyst (yfinance extras)

Retained Earnings
$63,632,126
Inventory
$8,821,331
Receivables
$27,461,362
ST Investments
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Jun 2025 95,017,570 45,733,209 36,172,518 271,750,012 30,941,386
Jun 2024 88,178,308 48,005,841 35,636,359 231,123,549 28,112,183
Jun 2023 78,321,318 44,102,498 30,604,566 193,713,556 29,082,413
Jun 2022 65,722,292 35,330,049 20,878,465 143,949,537 18,390,494

Peers — same industry

TickerNameMarket CapLastDaily %
KLAC KLA CORP $285.72B $218.73
TMO THERMO FISHER SCIENTIFIC INC. $212.69B $572.32
IBM INTERNATIONAL BUSINESS MACHINES CORP $194.69B $206.65
KXIAY Kioxia Holdings Corporation/ADR $179.44B $32.79
SMERY Siemens Energy AG/ADR $145.88B $34.29

News headlines (Yahoo Finance, 1h cache)

CLINUVEL implements strategic reorganisation to refocus on U.S. markets
2026-07-23 04:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.